Organovo Holdings PE Ratio 2011-2024 | ONVO

Current and historical p/e ratio for Organovo Holdings (ONVO) from 2011 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Organovo Holdings PE ratio as of September 10, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Organovo Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-09-11 0.55 0.00
2024-06-30 0.76 $-1.15 0.00
2024-03-31 1.03 $-1.61 0.00
2023-12-31 1.11 $-2.17 0.00
2023-09-30 1.25 $-2.14 0.00
2023-06-30 1.69 $-2.06 0.00
2023-03-31 2.19 $-1.97 0.00
2022-12-31 1.41 $-1.34 0.00
2022-09-30 2.05 $-1.37 0.00
2022-06-30 1.77 $-1.39 0.00
2022-03-31 3.76 $-1.31 0.00
2021-12-31 3.63 $-1.39 0.00
2021-09-30 6.80 $-1.36 0.00
2021-06-30 9.40 $-28.16 0.00
2021-03-31 9.64 $-28.27 0.00
2020-12-31 12.30 $-27.97 0.00
2020-09-30 7.91 $-28.20 0.00
2020-06-30 11.00 $-2.00 0.00
2020-03-31 8.20 $-2.60 0.00
2019-12-31 7.11 $-3.80 0.00
2019-09-30 5.21 $-4.40 0.00
2019-06-30 10.46 $-4.40 0.00
2019-03-31 19.84 $-4.80 0.00
2018-12-31 19.14 $-5.00 0.00
2018-09-30 23.00 $-5.20 0.00
2018-06-30 28.00 $-6.00 0.00
2018-03-31 20.60 $-6.60 0.00
2017-12-31 26.80 $-7.20 0.00
2017-09-30 44.40 $-7.60 0.00
2017-06-30 52.60 $-7.80 0.00
2017-03-31 63.60 $-7.60 0.00
2016-12-31 67.80 $-7.40 0.00
2016-09-30 75.80 $-7.80 0.00
2016-06-30 74.40 $-8.20 0.00
2016-03-31 43.40 $-8.40 0.00
2015-12-31 49.80 $-8.60 0.00
2015-09-30 53.60 $-8.20 0.00
2015-06-30 75.40 $-8.00 0.00
2015-03-31 70.80 $-7.60 0.00
2014-12-31 145.00 $-7.80 0.00
2014-09-30 127.40 $-7.40 0.00
2014-06-30 167.00 $-8.00 0.00
2014-03-31 152.80 $-7.60 0.00
2013-12-31 221.40 $-5.40 0.00
2013-09-30 115.40 $-4.00 0.00
2013-06-30 75.60 $12.60 6.00
2013-03-31 73.60 $-2.60 0.00
2012-12-31 52.00 $-2.60 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.007B $0.000B
Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $176.744B 17.68
Regeneron Pharmaceuticals (REGN) United States $125.265B 29.58
Vertex Pharmaceuticals (VRTX) United States $121.509B 0.00
Gilead Sciences (GILD) United States $101.392B 17.33
Bristol Myers Squibb (BMY) United States $99.910B 35.97
CSL (CSLLY) Australia $97.192B 0.00
GSK (GSK) United Kingdom $91.399B 10.60
Alnylam Pharmaceuticals (ALNY) United States $32.892B 0.00
Argenex SE (ARGX) Netherlands $31.991B 0.00
Moderna (MRNA) United States $30.475B 0.00
Biogen (BIIB) United States $29.226B 12.34
BioNTech SE (BNTX) Germany $23.926B 0.00
Illumina (ILMN) United States $19.774B 134.92
BeiGene (BGNE) Cayman Islands $19.181B 0.00
Genmab (GMAB) Denmark $18.188B 22.73
BioMarin Pharmaceutical (BMRN) United States $16.111B 47.67
Vaxcyte (PCVX) United States $12.972B 0.00
Insmed (INSM) United States $12.299B 0.00
Incyte (INCY) United States $12.159B 789.12
Sarepta Therapeutics (SRPT) United States $12.106B 275.96
Bio-Techne Corp (TECH) United States $11.702B 45.83
Exact Sciences (EXAS) United States $10.787B 0.00
QIAGEN (QGEN) Netherlands $10.475B 22.12
Bio-Rad Laboratories (BIO.B) United States $9.108B 30.17
Legend Biotech (LEGN) United States $9.079B 0.00
Roivant Sciences (ROIV) United Kingdom $9.015B 0.00
Repligen (RGEN) United States $8.216B 125.39
Intra-Cellular Therapies (ITCI) United States $7.773B 0.00
Halozyme Therapeutics (HALO) United States $7.507B 19.75
Exelixis (EXEL) United States $7.505B 23.08
Ascendis Pharma (ASND) Denmark $6.683B 0.00
Zealand Pharma (ZLDPF) Denmark $6.478B 0.00
Cytokinetics (CYTK) United States $6.371B 0.00
Viking Therapeutics (VKTX) United States $6.055B 0.00
Nuvalent (NUVL) United States $5.669B 0.00
Blueprint Medicines (BPMC) United States $5.447B 0.00
Krystal Biotech (KRYS) United States $5.315B 355.77
Ultragenyx Pharmaceutical (RARE) United States $5.135B 0.00
Apellis Pharmaceuticals (APLS) United States $4.771B 0.00
Avidity Biosciences (RNA) United States $4.479B 0.00
Alkermes (ALKS) Ireland $4.444B 15.60
Axsome Therapeutics (AXSM) United States $4.402B 0.00
Immunovant (IMVT) United States $4.350B 0.00
ADMA Biologics Inc (ADMA) United States $4.030B 66.50
Arcellx (ACLX) United States $3.988B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.877B 0.00
Denali Therapeutics (DNLI) United States $3.771B 0.00
Biohaven (BHVN) United States $3.398B 0.00
Merus (MRUS) Netherlands $3.389B 0.00
Amicus Therapeutics (FOLD) United States $3.337B 0.00
Guardant Health (GH) United States $3.175B 0.00
IDEAYA Biosciences (IDYA) United States $3.095B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.001B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.977B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.950B 0.00
Kymera Therapeutics (KYMR) United States $2.895B 0.00
SpringWorks Therapeutics (SWTX) United States $2.890B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.794B 0.00
Celldex Therapeutics (CLDX) United States $2.787B 0.00
Bavarian Nordic (BVNRY) Denmark $2.695B 14.56
Protagonist Therapeutics (PTGX) United States $2.646B 17.15
Geron (GERN) United States $2.616B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.593B 86.83
Iovance Biotherapeutics (IOVA) United States $2.569B 0.00
ImmunityBio (IBRX) United States $2.521B 0.00
Myriad Genetics (MYGN) United States $2.456B 0.00
CG Oncology (CGON) United States $2.423B 0.00
Twist Bioscience (TWST) United States $2.386B 0.00
Janux Therapeutics (JANX) United States $2.375B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.278B 0.00
Apogee Therapeutics (APGE) United States $2.228B 0.00
Vericel (VCEL) United States $2.138B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.134B 19.26
Vera Therapeutics (VERA) United States $2.059B 0.00
Keros Therapeutics (KROS) United States $2.052B 0.00
Intellia Therapeutics (NTLA) United States $2.044B 0.00
Novavax (NVAX) United States $2.033B 0.00
Zai Lab (ZLAB) China $2.022B 0.00
NeoGenomics (NEO) United States $2.002B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.993B 0.00
Structure Therapeutics (GPCR) United States $1.969B 0.00
Beam Therapeutics (BEAM) United States $1.949B 0.00
Galapagos (GLPG) Belgium $1.910B 0.00
Ligand Pharmaceuticals (LGND) United States $1.868B 31.75
NovoCure (NVCR) Jersey $1.829B 0.00
Neumora Therapeutics (NMRA) United States $1.807B 0.00
Akero Therapeutics (AKRO) United States $1.787B 0.00
Fortrea Holdings (FTRE) United States $1.784B 55.31
Rocket Pharmaceuticals (RCKT) United States $1.783B 0.00
Certara (CERT) United States $1.771B 57.95
Arvinas (ARVN) United States $1.751B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.719B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.714B 0.00
MannKind (MNKD) United States $1.655B 60.20
Edgewise Therapeutics (EWTX) United States $1.619B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.601B 0.00
Nurix Therapeutics (NRIX) United States $1.573B 0.00
Arcus Biosciences (RCUS) United States $1.525B 0.00
Kura Oncology (KURA) United States $1.513B 0.00
Belite Bio (BLTE) United States $1.497B 0.00
Disc Medicine (IRON) United States $1.473B 0.00
Dynavax Technologies (DVAX) United States $1.466B 101.73
Spyre Therapeutics (SYRE) United States $1.435B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.374B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.284B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.271B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.258B 0.00
Gyre Therapeutics (GYRE) United States $1.243B 0.00
Viridian Therapeutics (VRDN) United States $1.198B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.196B 0.00
Cogent Biosciences (COGT) United States $1.169B 0.00
ANI Pharmaceuticals (ANIP) United States $1.167B 15.85
Tyra Biosciences (TYRA) United States $1.133B 0.00
Prothena (PRTA) Ireland $1.116B 0.00
Sana Biotechnology (SANA) United States $1.112B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.096B 0.00
Vir Biotechnology (VIR) United States $1.090B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.067B 0.00
Praxis Precision Medicines (PRAX) United States $1.053B 0.00
CARGO Therapeutics (CRGX) United States $1.039B 0.00
Cullinan Therapeutics (CGEM) United States $1.033B 0.00
Immatics (IMTX) Germany $1.010B 0.00
Travere Therapeutics (TVTX) United States $0.982B 0.00
Tango Therapeutics (TNGX) United States $0.974B 0.00
AnaptysBio (ANAB) United States $0.964B 0.00
ArriVent BioPharma (AVBP) United States $0.917B 0.00
MiMedx (MDXG) United States $0.915B 25.96
Immunome (IMNM) United States $0.879B 0.00
Erasca (ERAS) United States $0.876B 0.00
Arbutus Biopharma (ABUS) United States $0.861B 0.00
Zymeworks (ZYME) United States $0.854B 0.00
Sinovac Biotech (SVA) China $0.844B 0.00
Stoke Therapeutics (STOK) United States $0.838B 0.00
89BIO (ETNB) United States $0.820B 0.00
Dianthus Therapeutics (DNTH) United States $0.816B 0.00
Castle Biosciences (CSTL) United States $0.809B 0.00
Pliant Therapeutics (PLRX) United States $0.789B 0.00
AbCellera Biologics (ABCL) Canada $0.760B 0.00
Abivax SA (ABVX) France $0.744B 0.00
WAVE Life Sciences (WVE) Singapore $0.743B 0.00
Cytek Biosciences (CTKB) United States $0.735B 0.00
Nuvation Bio (NUVB) United States $0.733B 0.00
Terns Pharmaceuticals (TERN) United States $0.726B 0.00
Rapport Therapeutics (RAPP) $0.722B 0.00
Scholar Rock Holding (SRRK) United States $0.719B 0.00
Replimune (REPL) United States $0.706B 0.00
Olema Pharmaceuticals (OLMA) United States $0.706B 0.00
Oric Pharmaceuticals (ORIC) United States $0.703B 0.00
Mesoblast (MESO) Australia $0.696B 0.00
Revance Therapeutics (RVNC) United States $0.689B 0.00
Liquidia Technologies (LQDA) United States $0.683B 0.00
CureVac (CVAC) Germany $0.683B 0.00
Avid Bioservices (CDMO) United States $0.669B 0.00
IGM Biosciences (IGMS) United States $0.669B 0.00
Annexon (ANNX) United States $0.660B 0.00
LENZ Therapeutics (LENZ) United States $0.658B 0.00
Astria Therapeutics (ATXS) United States $0.639B 0.00
Adaptive Biotechnologies (ADPT) United States $0.628B 0.00
Humacyte (HUMA) United States $0.627B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.597B 0.00
Mineralys Therapeutics (MLYS) United States $0.597B 0.00
Applied Therapeutics (APLT) United States $0.597B 0.00
Allogene Therapeutics (ALLO) United States $0.592B 0.00
Celcuity (CELC) United States $0.590B 0.00
ITeos Therapeutics (ITOS) United States $0.584B 0.00
REGENXBIO (RGNX) United States $0.583B 0.00
Q32 Bio (QTTB) United States $0.578B 0.00
Alector (ALEC) United States $0.562B 0.00
Entrada Therapeutics (TRDA) United States $0.548B 4.97
Alumis (ALMS) United States $0.542B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.532B 0.00
Fulcrum Therapeutics (FULC) United States $0.526B 0.00
Third Harmonic Bio (THRD) United States $0.515B 0.00
Neurogene (NGNE) United States $0.493B 0.00
ACELYRIN, INC (SLRN) United States $0.492B 0.00
Oculis Holding AG (OCS) Switzerland $0.486B 0.00
Prime Medicine (PRME) United States $0.480B 0.00
Pharming Group (PHAR) Netherlands $0.478B 0.00
PureTech Health (PRTC) United States $0.474B 0.00
Contineum Therapeutics (CTNM) United States $0.464B 0.00
Nkarta (NKTX) United States $0.459B 0.00
C4 Therapeutics (CCCC) United States $0.452B 0.00
Aura Biosciences (AURA) United States $0.447B 0.00
Fate Therapeutics (FATE) United States $0.435B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.430B 0.00
Anavex Life Sciences (AVXL) United States $0.424B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.421B 0.00
Absci (ABSI) United States $0.417B 0.00
GH Research (GHRS) Ireland $0.417B 0.00
MaxCyte (MXCT) United States $0.416B 0.00
GRAIL (GRAL) United States $0.416B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.411B 0.00
Emergent Biosolutions (EBS) United States $0.411B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.405B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.390B 0.00
Northwest Biotherapeutics (NWBO) United States $0.386B 0.00
G1 Therapeutics (GTHX) United States $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.364B 175.64
Alto Neuroscience (ANRO) United States $0.363B 0.00
Sutro Biopharma (STRO) United States $0.362B 0.00
Ocugen (OCGN) United States $0.357B 0.00
Nautilus Biotechnology (NAUT) United States $0.354B 0.00
CorMedix Inc (CRMD) United States $0.348B 0.00
Voyager Therapeutics (VYGR) United States $0.340B 22.25
Inozyme Pharma (INZY) United States $0.330B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.327B 0.00
XOMA Royalty (XOMA) United States $0.324B 0.00
Design Therapeutics (DSGN) United States $0.319B 0.00
Cartesian Therapeutics (RNAC) United States $0.318B 0.00
Urogen Pharma (URGN) United States $0.315B 0.00
TScan Therapeutics (TCRX) United States $0.314B 0.00
Atea Pharmaceuticals (AVIR) United States $0.313B 0.00
Editas Medicine (EDIT) United States $0.311B 0.00
Kyverna Therapeutics (KYTX) United States $0.308B 0.00
Prima BioMed (IMMP) Australia $0.307B 0.00
Jasper Therapeutics (JSPR) United States $0.306B 0.00
AC Immune (ACIU) Switzerland $0.305B 0.00
Solid Biosciences (SLDB) United States $0.303B 0.00
Kamada (KMDA) Israel $0.303B 19.52
Vanda Pharmaceuticals (VNDA) United States $0.290B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.290B 0.00
Rezolute (RZLT) United States $0.288B 0.00
Poseida Therapeutics (PSTX) United States $0.288B 0.00
EnGene Holdings (ENGN) Canada $0.287B 0.00
Artiva Biotherapeutics (ARTV) United States $0.286B 0.00
PepGen (PEPG) United States $0.284B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Alimera Sciences (ALIM) United States $0.282B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.276B 0.00
Biomea Fusion (BMEA) United States $0.274B 0.00
MeiraGTx Holdings (MGTX) United States $0.264B 0.00
UniQure (QURE) Netherlands $0.259B 0.00
Tectonic Therapeutic (TECX) United States $0.258B 0.00
ChromaDex (CDXC) United States $0.251B 0.00
ScPharmaceuticals (SCPH) United States $0.250B 0.00
Precigen (PGEN) United States $0.247B 0.00
Amarin (AMRN) Ireland $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.241B 0.00
Alpha Teknova (TKNO) United States $0.236B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.233B 0.00
2seventy Bio (TSVT) United States $0.232B 0.00
Trevi Therapeutics (TRVI) United States $0.229B 0.00
Zura Bio (ZURA) United States $0.222B 0.00
Inhibrx Biosciences (INBX) $0.220B 0.00
Compass Therapeutics (CMPX) United States $0.217B 0.00
Cabaletta Bio (CABA) United States $0.217B 0.00
Candel Therapeutics (CADL) United States $0.217B 0.00
Skye Bioscience (SKYE) United States $0.212B 0.00
GENFIT S.A (GNFT) France $0.211B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.210B 0.00
Gossamer Bio (GOSS) United States $0.208B 0.00
Scilex Holding (SCLX) United States $0.207B 0.00
Molecular Partners AG (MOLN) Switzerland $0.206B 0.00
XBiotech (XBIT) United States $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.194B 0.00
Greenwich LifeSciences (GLSI) United States $0.193B 0.00
Innate Pharma S.A (IPHA) France $0.193B 0.00
Codexis (CDXS) United States $0.191B 0.00
Oncobiologics (OTLK) United States $0.184B 0.00
Shattuck Labs (STTK) United States $0.184B 0.00
Tenaya Therapeutics (TNYA) United States $0.181B 0.00
Sangamo Therapeutics (SGMO) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.179B 0.00
Opthea (OPT) Australia $0.179B 0.00
Caribou Biosciences (CRBU) United States $0.177B 0.00
Compugen (CGEN) Israel $0.173B 0.00
Inovio Pharmaceuticals (INO) United States $0.167B 0.00
Generation Bio (GBIO) United States $0.166B 0.00
Instil Bio (TIL) United States $0.160B 0.00
BioStem Technologies (BSEM) $0.157B 24.69
Actuate Therapeutics (ACTU) United States $0.157B 0.00
Coherus BioSciences (CHRS) United States $0.157B 0.00
Seres Therapeutics (MCRB) United States $0.156B 0.00
Ventyx Biosciences (VTYX) United States $0.153B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.151B 0.00
Vigil Neuroscience (VIGL) United States $0.150B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.150B 0.00
Lifecore Biomedical (LFCR) United States $0.150B 0.00
Adverum Biotechnologies (ADVM) United States $0.149B 0.00
23andMe Holding (ME) United States $0.147B 0.00
ATyr Pharma (ATYR) United States $0.144B 0.00
Adherex Technologies (FENC) United States $0.143B 131.00
Elutia (ELUT) United States $0.141B 0.00
Rani Therapeutics Holdings (RANI) United States $0.140B 0.00
Adagene (ADAG) China $0.137B 0.00
FibroBiologics (FBLG) United States $0.137B 0.00
Immunic (IMUX) United States $0.133B 0.00
Akoya Biosciences (AKYA) United States $0.131B 0.00
Kodiak Sciences (KOD) United States $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.124B 0.00
Cellectis S.A (CLLS) France $0.123B 0.00
Repare Therapeutics (RPTX) Canada $0.122B 0.00
INmune Bio (INMB) United States $0.119B 0.00
Adicet Bio (ACET) United States $0.118B 0.00
Agenus (AGEN) United States $0.118B 0.00
Puma Biotechnology (PBYI) United States $0.117B 12.58
Nuvectis Pharma (NVCT) United States $0.117B 0.00
X4 Pharmaceuticals (XFOR) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.114B 0.00
ALX Oncology Holdings (ALXO) United States $0.114B 0.00
Sagimet Biosciences (SGMT) United States $0.114B 0.00
PDS Biotechnology (PDSB) United States $0.111B 0.00
Verastem (VSTM) United States $0.110B 0.00
Annovis Bio (ANVS) United States $0.109B 0.00
Invivyd (IVVD) United States $0.108B 0.00
Cardiff Oncology (CRDF) United States $0.107B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
CytomX Therapeutics (CTMX) United States $0.102B 9.36
Renovaro (RENB) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Seer (SEER) United States $0.098B 0.00
Werewolf Therapeutics (HOWL) United States $0.097B 0.00
Checkpoint Therapeutics (CKPT) United States $0.096B 0.00
MediciNova (MNOV) United States $0.096B 0.00
CervoMed (CRVO) United States $0.096B 0.00
BioHarvest Sciences (CNVCF) Canada $0.093B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.090B 0.00
I-Mab (IMAB) China $0.089B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
Benitec Biopharma (BNTC) United States $0.088B 0.00
BioAtla (BCAB) United States $0.087B 0.00
Genelux (GNLX) United States $0.087B 0.00
HilleVax (HLVX) United States $0.087B 0.00
VistaGen Therapeutics (VTGN) United States $0.087B 0.00
InflaRx (IFRX) Germany $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Cidara Therapeutics (CDTX) United States $0.084B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
BeyondSpring (BYSI) United States $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Adlai Nortye (ANL) Cayman Islands $0.081B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.079B 0.00
Ovid Therapeutics (OVID) United States $0.079B 0.00
Chimerix (CMRX) United States $0.079B 0.00
Genenta Science S.p.A (GNTA) Italy $0.077B 0.00
Semper Paratus Acquisition (TVGN) United States $0.076B 0.00
Vor Biopharma (VOR) $0.075B 0.00
Oncolytics Biotech (ONCY) Canada $0.075B 0.00
Precision BioSciences (DTIL) United States $0.074B 0.00
DBV Technologies S.A (DBVT) France $0.073B 0.00
Spero Therapeutics (SPRO) United States $0.073B 3.29
Leap Therapeutics (LPTX) United States $0.072B 0.00
Boundless Bio (BOLD) United States $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Connect Biopharma Holdings (CNTB) United States $0.070B 0.00
Rapt Therapeutics (RAPT) United States $0.069B 0.00
Omega Therapeutics (OMGA) United States $0.069B 0.00
Entera Bio (ENTX) Israel $0.067B 0.00
Imunon (IMNN) United States $0.066B 0.00
TELA Bio (TELA) United States $0.065B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Gritstone Bio (GRTS) United States $0.060B 0.00
Aileron Therapeutics (ALRN) United States $0.059B 0.00
Affimed (AFMD) Germany $0.059B 0.00
HOOKIPA Pharma (HOOK) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Celularity (CELU) United States $0.058B 0.00
Intensity Therapeutics (INTS) United States $0.057B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.056B 0.00
Lexaria Bioscience (LEXX) Canada $0.056B 0.00
Theratechnologies (THTX) Canada $0.055B 0.00
Aerovate Therapeutics (AVTE) United States $0.055B 0.00
Allakos (ALLK) United States $0.053B 0.00
CalciMedica (CALC) United States $0.052B 0.00
Immix Biopharma (IMMX) United States $0.052B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.050B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.049B 0.00
Passage Bio (PASG) United States $0.048B 0.00
Elicio Therapeutics (ELTX) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
LakeShore Biopharma (LSB) China $0.043B 0.00
Atara Biotherapeutics (ATRA) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Syros Pharmaceuticals (SYRS) United States $0.042B 0.00
Kezar Life Sciences (KZR) United States $0.041B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.041B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Dyadic (DYAI) United States $0.038B 0.00
NextCure (NXTC) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Bionano Genomics (BNGO) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
Elevation Oncology (ELEV) United States $0.036B 0.00
Immuneering (IMRX) United States $0.035B 0.00
Ocean Biomedical (OCEA) United States $0.035B 0.00
ARCA Biopharma (ORKA) United States $0.034B 0.00
Ocuphire Pharma (OCUP) United States $0.034B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.032B 0.00
Equillium (EQ) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Quince Therapeutics (QNCX) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Curis (CRIS) United States $0.029B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.029B 0.00
Longeveron (LGVN) United States $0.029B 0.00
Lumos Pharma (LUMO) United States $0.029B 0.00
Orgenesis (ORGS) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Cue Biopharma (CUE) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
KALA BIO (KALA) United States $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.025B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
Bolt Biotherapeutics (BOLT) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
UNITY Biotechnology (UBX) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.023B 0.00
BioXcel Therapeutics (BTAI) United States $0.022B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.022B 0.00
HCW Biologics (HCWB) United States $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Cyclo Therapeutics (CYTH) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Evaxion Biotech (EVAX) Denmark $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Turnstone Biologics (TSBX) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
IN8bio (INAB) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
ANEW Medical (WENA) United States $0.014B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Tenax Therapeutics (TENX) United States $0.013B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.012B 0.00
Apollomics (APLM) United States $0.012B 0.00
Evogene (EVGN) Israel $0.012B 0.00
BRIACELL THERAP (BCTX) Canada $0.011B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Forte Biosciences (FBRX) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Kintara Therapeutics (KTRA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Kineta (KA) United States $0.009B 0.00
Monopar Therapeutics (MNPR) United States $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Hoth Therapeutics (HOTH) United States $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
COSCIENS Biopharma (CSCI) Canada $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
TFF Pharmaceuticals (TFFP) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Notable Labs (NTBL) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.005B 0.00
Quantum Biopharma (QNTM) Canada $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Citius Oncology (CTOR) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Entero Therapeutics (ENTO) United States $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GENPREX (GNPX) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00